Your browser doesn't support javascript.
loading
Controlling drug release with additive manufacturing-based solutions.
Patel, Shriya K; Khoder, Mouhamad; Peak, Matthew; Alhnan, Mohamed A.
Affiliation
  • Patel SK; Institute of Pharmaceutical Science, King's College London, London, UK.
  • Khoder M; Drug Discovery, Delivery and Patient Care (DDDPC) Theme, School of Life Sciences, Pharmacy and Chemistry, Kingston University London, Kingston Upon Thames, London, UK.
  • Peak M; Paediatric Medicines Research Unit, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
  • Alhnan MA; Institute of Pharmaceutical Science, King's College London, London, UK. Electronic address: Alhnan@kcl.ac.uk.
Adv Drug Deliv Rev ; 174: 369-386, 2021 07.
Article de En | MEDLINE | ID: mdl-33895213
ABSTRACT
3D printing is an innovative manufacturing technology with great potential to revolutionise solid dosage forms. Novel features of 3D printing technology confer advantage over conventional solid dosage form manufacturing technologies, including rapid prototyping and an unparalleled capability to fabricate complex geometries with spatially separated conformations. Such a novel technology could transform the pharmaceutical industry, enabling the production of highly personalised dosage forms with well-defined release profiles. In this work, we review the current state of the art of using additive manufacturing for predicting and understanding drug release from 3D printed novel structures. Furthermore, we describe a wide spectrum of 3D printing technologies, materials, procedure, and processing parameters used to fabricate fundamentally different matrices with different drug releases. The different methods to manipulate drug release patterns including the surface area-to-mass ratio, infill pattern, geometry, and composition, are critically evaluated. Moreover, the drug release mechanisms and models that could aid exploiting the release profile are also covered. Finally, this review also covers the design opportunities alongside the technical and regulatory challenges that these rapidly evolving technologies present.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Technologie pharmaceutique / Impression tridimensionnelle Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Adv Drug Deliv Rev Sujet du journal: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Année: 2021 Type de document: Article Pays d'affiliation: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Technologie pharmaceutique / Impression tridimensionnelle Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Adv Drug Deliv Rev Sujet du journal: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Année: 2021 Type de document: Article Pays d'affiliation: Royaume-Uni
...